Please select the option that best describes you:
What starting dose of lenvatinib are you ultilizing in recurrent endometrial cancer patients initiating lenvatinib/pembro?
Answer from: at Academic Institution
I start with 20 mg daily.
I base this on the recent study by Makker and colleagues
Sign In or Register to read more